Sharvil P Patel

Jump to

Cadila re-appoints Sharvil P Patel as MD for another five-year term

The company’s board based on the recommendation of the nomination and remuneration committee and subject to approval of the members of the company has approved the proposal to re-appoint Patel as the MD for a further period of five years till March 31, 2027, the drug firm said in a regulatory filing.
Pankaj Patel steps down as Cadila MD, son Sharvil to take over

The Board of Directors of Cadila Healthcare has unanimously approved the appointment of Sharvil P Patel as the Manging Director of the company, Cadila Healthcare said in a filing to BSE.
Zydus acquires skin treatment lotion Melgain from Issar Pharma

Melgain will be marketed in India by Liva Healthcare, a specialty division of the group catering to the dermatological segment, Cadila Healthcare said in a filing to BSE.

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347

Sharvil P Patel

Cadila re-appoints Sharvil P Patel as MD for another five-year term

Pankaj Patel steps down as Cadila MD, son Sharvil to take over

Zydus acquires skin treatment lotion Melgain from Issar Pharma